Study on the method to avoid infusion-site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells
暂无分享,去创建一个
T. Murakami | K. Oda | N. Mori | K. Omoda | Y. Maeda | M. Yamasaki | T. Nishida | Shoko Tominaga | Takashi Ichinose | Marie Mizuguchi